2015 American Transplant Congress

Saturday, May 2, 2015

5:30pm-7:30pm

Evaluation of the Gastrointestinal Tract as a Potential Route of Primary Polyomavirus Infection

G. Huang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²

Poster Session A: BK Virus Infection  •  Exhibit Hall E

5:30pm-7:30pm

Evaluation of the Use of Leflunomide for the Prevention of BK Nephropathy in Renal Transplant Recipients- A Single Center Experience

S. Jonchhe, E. Hollinger, S. Jensik, O. Olaitan, A. Hodowanec, M. Hertl, S. Fayek, E. Chan, C. Pullum, N. Alvey.

Poster Session A: BK Virus Infection  •  Exhibit Hall E

5:30pm-7:30pm

Everolimus With Low Dose Tacrolimus in Intestinal Transplantation

T. Beduschi, J. Garcia, J. Lugo-Baruqui, J. Fan, S. Nishida, J. Jebrock, A. Tekin, G. Selvaggi, P. Ruiz, R. Vianna.

Poster Session A: Small Bowel All Topics  •  Exhibit Hall E

5:30pm-7:30pm

Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation

P. De Simone,¹ P. Carrai,¹ L. Coletti,¹ D. Ghinolfi,¹ D. Campani,² F. Filipponi.¹

Poster Session A: Liver: Immunosuppression and Rejection  •  Exhibit Hall E

5:30pm-7:30pm

Excellent Outcomes of Prophylactic Rituximab Administration With Plasmapheresis in Kidney Transplant Recipients With Focal Segmental Glomerulosclerosis

M. Okumi,¹ Y. Miyauchi,² T. Yagisawa,¹ K. Unagami,¹ D. Toki,¹ K. Omoto,¹ H. Ishida,¹ K. Tanabe.¹

Poster Session A: Delayed Function/Acute Injury/Outcomes/Glomerulonephritis  •  Exhibit Hall E

5:30pm-7:30pm

Exercise Therapy Improves Body Composition Change After Kidney Transplantation

M. Miura, H. Higashiyama.

Poster Session A: Kidney: Cardiovascular and Metabolic  •  Exhibit Hall E

5:30pm-7:30pm

Factors Associated With Rehospitalization and High Cost Among Health Plan Members Receiving Kidney Transplants

E. Lee,¹ Y. Zhou,² B. Suehs,² B. Franks,¹ B. Kassman,¹ J. Spalding,¹ G. Thal.¹

Poster Session A: Non Organ Specific, Economics, Public Policy, Allocation, Ethics  •  Exhibit Hall E

5:30pm-7:30pm

Factors Influencing Cost Among Kidney, Liver, and Heart Transplant Patients in a Private Payer Setting

W. Bannister,¹ C. Wu,¹ M. Schnitzler,² F. Irwin,¹ A. Bonagura.¹

Poster Session A: Non Organ Specific, Economics, Public Policy, Allocation, Ethics  •  Exhibit Hall E

5:30pm-7:30pm

Feasibility of Regulatory T Cell Cryopreservation and Banking for Clinical Therapeutic Applications

K. Gołąb,¹ O. Savari,¹ S. Ramachandran,¹ Z. Tekin,¹ M. Tibudan,¹ J. Millis,¹ P. Trzonkowski,² P. Witkowski.¹

Poster Session A: Preclinical Immunosuppression and Tolerance  •  Exhibit Hall E

5:30pm-7:30pm

Financial Impact of an Advanced Liver Disease Service on a Tertiary Health System

A. Masoumi,¹ S. Hanish,² J. LaMattina,² C. Njoka,¹ W. Hutson,² D. Potosky,² R. Barth.²

Poster Session A: Non Organ Specific, Economics, Public Policy, Allocation, Ethics  •  Exhibit Hall E